Introducing the Tehran Heart Center’s Premature Coronary Atherosclerosis Cohort: THC-PAC Study
Abstract Background: Data on premature coronary artery disease (CAD) are scarce. The Tehran Heart Center’s Premature Coronary Atherosclerosis Cohort Study (THC-PAC) is the first study of its kind in the Middle East to assess major adverse cardiac events (MACE) in young CAD patients. Methods: The cohort consists of CAD patients, males ≤ 45 years old and females ≤ 55 years old. The participants are residents of Tehran or its suburbs and underwent coronary angiography between June 2004 and July 2011.
This article is available to registered members
Create a free account to access our full library of peer-reviewed research on medical cannabis.
Join — it's freeAlready a member? Log in